Evaluation of the Enoxaparin in the Prophylaxis of Deep Venous Thrombosis
Phase 2
- Conditions
- Deep vein thrombosi.Other venous embolism and thrombosis
- Registration Number
- IRCT20130917014693N11
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age between 18 and 65 years old
Padua risk score = 4 points
Signing the informed consent form
Exclusion Criteria
Patients in shock state
Acute kidney injury
Chronic kidney injury
History of hemorrhage in past one month
Invasive surgical procedures which needs to enoxaparin discontinuation
Pregnancy
Lactation
Thrombophilia
Antithrombin deficiency
Previous history of venous thrombosis
Body mass index more than 35 kg/m2
Platelet less than 50000 cells/uL
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The activity level of anti factor Xa. Timepoint: Three hours after third doses. Method of measurement: Chromogenic assay.
- Secondary Outcome Measures
Name Time Method Occurance rate of deep vein thrombosis. Timepoint: Daily. Method of measurement: Clinical examination and sonography is necessary cases.;Occurrence rate of adverse drug reactions. Timepoint: Daily. Method of measurement: Observation.